Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors NEW HAVEN, Conn., May 15, 2024 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for...

Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer